全文获取类型
收费全文 | 1227篇 |
免费 | 82篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 88篇 |
妇产科学 | 24篇 |
基础医学 | 170篇 |
口腔科学 | 21篇 |
临床医学 | 95篇 |
内科学 | 255篇 |
皮肤病学 | 10篇 |
神经病学 | 87篇 |
特种医学 | 35篇 |
外科学 | 204篇 |
综合类 | 34篇 |
一般理论 | 3篇 |
预防医学 | 56篇 |
眼科学 | 13篇 |
药学 | 122篇 |
中国医学 | 2篇 |
肿瘤学 | 85篇 |
出版年
2022年 | 9篇 |
2021年 | 34篇 |
2020年 | 13篇 |
2019年 | 27篇 |
2018年 | 39篇 |
2017年 | 21篇 |
2016年 | 35篇 |
2015年 | 28篇 |
2014年 | 41篇 |
2013年 | 52篇 |
2012年 | 95篇 |
2011年 | 76篇 |
2010年 | 36篇 |
2009年 | 35篇 |
2008年 | 67篇 |
2007年 | 68篇 |
2006年 | 60篇 |
2005年 | 49篇 |
2004年 | 42篇 |
2003年 | 41篇 |
2002年 | 41篇 |
2001年 | 25篇 |
2000年 | 30篇 |
1999年 | 26篇 |
1998年 | 10篇 |
1997年 | 6篇 |
1996年 | 7篇 |
1995年 | 7篇 |
1992年 | 12篇 |
1991年 | 19篇 |
1990年 | 13篇 |
1989年 | 15篇 |
1988年 | 18篇 |
1987年 | 11篇 |
1986年 | 13篇 |
1985年 | 12篇 |
1984年 | 8篇 |
1983年 | 9篇 |
1981年 | 11篇 |
1980年 | 9篇 |
1979年 | 12篇 |
1978年 | 7篇 |
1976年 | 7篇 |
1974年 | 9篇 |
1973年 | 9篇 |
1972年 | 9篇 |
1971年 | 17篇 |
1970年 | 9篇 |
1968年 | 5篇 |
1967年 | 10篇 |
排序方式: 共有1311条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
B. Vaidya P. E. Harris P. Barrett P. Kendall-Taylor 《Postgraduate medical journal》1997,73(866):817-819
We report a case of Riedel''s thyroiditis presenting with a systemic illness, life-threatening stridor and a stony hard goitre. Diagnosis was confirmed by open thyroid biopsy. Treatment with corticosteroid resulted in a dramatic improvement. A possible autoimmune mechanism in the pathogenesis of Riedel''s thyroiditis is discussed. 相似文献
5.
6.
7.
8.
The Indian population can be divided broadly into Dravidians and the Aryans. In this report, we have attempted to analyze the HLA genetic profile of 400 native North Indian Hindus of Aryan descent. The gene frequencies of a majority of class I and II antigens show similarity to the Caucasoid population. An interesting finding was a complete lack of antigen B14 while B16 and B41 occurred with the least frequency. Haplotype A10, B8 with significant positive linkage disequilibrium as well as showing the highest incidence is characteristic of North Indians. 相似文献
9.
Mehta H Mahajan A Bansal N Vaidya S Pathak L 《The Journal of the Association of Physicians of India》1998,46(11):953-956
The above discussion on the interaction of aspirin and ACE inhibitors seems to suggest that aspirin in high doses may have adverse interaction with ACE inhibitors in patients with heart failure but the data obtained is not sufficient or conclusive to recommended omission of aspirin in patients with heart failure. This raises a query in the mind of the physician whether to use a combination or not? The role of aspirin in the early period after myocardial infarction is well established so is the role of ACE inhibitors. Hence in patients with myocardial infarction and preserved left ventricular function it would not be wrong to administer combination of ACE inhibitors and aspirin. Albeit at a lower dose. In patients with large myocardial infarction or heart failure, warfarin may be an option but still needs to be documented in large trials. As suggested long term use of aspirin after infarction is still ambiguous and may be harmful in patients with heart failure with its anticedent side effects. But long term benefits of ACE inhibitors in heart failure are well documented. Hence if a choice has to be made whether to discontinue either of the two drugs it would be preferable to stop the aspirin. To answer the issue of use of aspirin in patients with heart failure it would be essential to conduct a double blind randomized trial comparing known anti-thrombotic treatment, aspirin and anti-coagulants on mortality in patients with heart failure, especially caused by coronary artery disease. Such a trial is underway at the present and till the results are available it should be left to clinical judgement of the physician whether to administer aspirin in patients with heart failure after weighing the benefits versus risk. 相似文献
10.
Bhatt AD Dalal DG Shah SJ Joshi BA Gajjar MN Vaidya RA Vaidya AB Antarkar DS 《Journal of postgraduate medicine》1995,41(1):5-7
An open comparative trial was conducted in 58 adult obese patients (Body Mass Index > or = 25 kg/square metre). Group I (n = 27), non-drug, was advised diet (1200-1600 cals) and a brisk walk for 30 minutes. Group II, in addition, received Guggulu (Medohar) 1.5-3 gms/day for 30 days. Mean difference in weight loss between Guggulu and non-drug group was 0.32 kg (ns) on day 15 and 0.58 kg on day 30 (ns). The mean weight reduction in patients (> 90 kgs) was 1.92 kg (ns) and 2.25 kg (ns) higher in Guggulu group. All patients weighing > 90 kg lost weight in Guggulu group whilst 3 in non-drug group did not lose weight. Guggulu was tolerated well. The data from this pilot study suggest a synergistic diet-Guggulu interaction over 30 days in patients weighing > 90 kgs which needs to be confirmed in a large placebo controlled study. 相似文献